|
Therapeutic Compounds to Enhance Cognition, Counteract Depression and Treat Smoking Addiction
Chemicals Selectively Modulate Cell Receptors Linked to Neurological Disorders in Humans and Other MammalsThese compounds enable effective treatment of neurological disorders involving cognitive deficits (including Alzheimer’s and Parkinson’s diseases), depression and drug dependences such as tobacco (nicotine) and betel nut addictions....
Published: 6/27/2021
|
Inventor(s): William Kem, Ferenc Soti, Hong Xing
Keywords(s): Alzheimer's Disease, Anti-Inflammatory, Cognition Enhancer, Dementia, Parkinson's Disease, Post Traumatic Stress Disorder, Schizophrenia, Wound Healing
Category(s): Technology Classifications > Human Health Care > Therapeutics
|
|
AAV Vector that Promotes Antioxidant Production for Treatment of Age-Related Macular Degeneration
Gene Therapy Requires Just One Intraocular Injection to Treat Eye Ailment Caused by Oxidative StressThis AAV gene therapy approach provides a one-time treatment to oxidative stress. Sustained oxidative stress can lead to a variety of pathophysiological diseases including age-related macular degeneration, diabetic retinopathy, and amyotrophic lateral...
Published: 12/22/2022
|
Inventor(s): Qiuhong Li, Christhian Ildefonso, Alfred Lewin
Keywords(s): Age Related Macular Degeneration, Alzheimer's Disease, Diabetic Retinopathy, Gene Therapy, Macular Degeneration, Retinal Degeneration, uveitis
Category(s): Technology Classifications > Human Health Care > Gene Therapy, Technology Classifications > Human Health Care > Others
|
|
Soluble, Toll-Like Receptor Decoys for Treating Neurodegenerative Diseases
Protein Receptors Provide Immunotherapy Treatments for Proteinopathy DiseasesThese decoy protein receptors can be used to treat neurodegenerative diseases. Neurodegenerative diseases, including Alzheimer’s and Parkinson’s, affect more than 6 million people in the United States. Over time and with age, the body’s natural protein growth...
Published: 6/27/2021
|
Inventor(s): Todd Golde, Thomas Ladd, Pedro Cruz, Yona Levites, Paramita Chakrabarty, Andrew Li
Keywords(s): Alzheimer's Disease, Therapeutics
Category(s): Technology Classifications > Human Health Care > Therapeutics
|
